WO2006099451A3 - Novel human, feline, chicken and other animal interferons and uses thereof - Google Patents

Novel human, feline, chicken and other animal interferons and uses thereof Download PDF

Info

Publication number
WO2006099451A3
WO2006099451A3 PCT/US2006/009229 US2006009229W WO2006099451A3 WO 2006099451 A3 WO2006099451 A3 WO 2006099451A3 US 2006009229 W US2006009229 W US 2006009229W WO 2006099451 A3 WO2006099451 A3 WO 2006099451A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
chicken
novel
feline
interferon
Prior art date
Application number
PCT/US2006/009229
Other languages
French (fr)
Other versions
WO2006099451A2 (en
Inventor
Sidney Pestka
Christopher D Krause
Original Assignee
Univ New Jersey Med
Sidney Pestka
Christopher D Krause
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New Jersey Med, Sidney Pestka, Christopher D Krause filed Critical Univ New Jersey Med
Priority to EP06748385A priority Critical patent/EP1859042A2/en
Publication of WO2006099451A2 publication Critical patent/WO2006099451A2/en
Publication of WO2006099451A3 publication Critical patent/WO2006099451A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]

Abstract

The invention relates to novel interferon polypeptides and nucleic from humans, felines, chicken and other species and to related compositions and uses. The invention also provides novel interleukin polypeptides and nucleic acids, as well as nucleic acids and polypeptides for interferons and interleukin receptors. The invention also provides antibodies specific for the novel polypeptides, assays for identifying modulators of interferon activity, and methods of treating animals, including humans, afflicted with various disorders and conditions by administering interferon polypeptides, including IFN-P polypeptides and fragments.
PCT/US2006/009229 2005-03-14 2006-03-14 Novel human, feline, chicken and other animal interferons and uses thereof WO2006099451A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06748385A EP1859042A2 (en) 2005-03-14 2006-03-14 Novel human, feline, chicken and other animal interferons and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66168605P 2005-03-14 2005-03-14
US60/661,686 2005-03-14
US66444305P 2005-03-22 2005-03-22
US60/664,443 2005-03-22

Publications (2)

Publication Number Publication Date
WO2006099451A2 WO2006099451A2 (en) 2006-09-21
WO2006099451A3 true WO2006099451A3 (en) 2007-03-15

Family

ID=36968759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/009229 WO2006099451A2 (en) 2005-03-14 2006-03-14 Novel human, feline, chicken and other animal interferons and uses thereof

Country Status (2)

Country Link
EP (1) EP1859042A2 (en)
WO (1) WO2006099451A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7956161B2 (en) 2007-04-11 2011-06-07 Pestka Biomedical Laboratories, Inc. Interferons of rhesus and cynomolgus origin and uses thereof
KR101666229B1 (en) 2008-02-08 2016-10-14 메디뮨 엘엘씨 Anti-ifnar1 antibodies with reduced fc ligand affinity
WO2012037616A1 (en) * 2010-09-24 2012-03-29 Commonwealth Scientific And Industrial Research Organisation Interferon-nu
WO2014118385A1 (en) * 2013-02-04 2014-08-07 University of Tromsø The use of dna sequences encoding an interferon as vaccine adjuvants
CN113880956B (en) * 2021-11-01 2023-08-29 长春萤火虫生物科技有限公司 Recombinant cat interferon fusion protein and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036627A2 (en) * 2000-11-03 2002-05-10 Pbl Biomedical Laboratories Interferons, uses and compositions related thereto
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036627A2 (en) * 2000-11-03 2002-05-10 Pbl Biomedical Laboratories Interferons, uses and compositions related thereto
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EPO Proteins [online] 27 January 2003 (2003-01-27), "Sequence 50 from Patent WO0236627.", XP002400034, retrieved from EBI accession no. EPOP:AX592888 Database accession no. AX592888 *
DATABASE Geneseq [online] 2 December 2004 (2004-12-02), "Human interferon (IFN) alpha 4 protein.", XP002400035, retrieved from EBI accession no. GSP:ADS16313 Database accession no. ADS16313 *
DATABASE Geneseq [online] 21 May 2002 (2002-05-21), "Human protein NOV2.", XP002400036, retrieved from EBI accession no. GSP:AAU85404 Database accession no. AAU85404 *
DATABASE UniProt [online] 1 March 2002 (2002-03-01), "Interleukin 10 receptor 2 precursor", XP002400037, retrieved from EBI Database accession no. Q8VHM7 *
LILES W C ET AL: "REVIEW: NOMENCLATURE AND BIOLOGIC SIGNIFICANCE OF CYTOKINES INVOLVED IN INFLAMMATION AND THE HOST IMMUNE RESPONSE", JOURNAL OF INFECTIOUS DISEASES, CHICAGO, IL, US, vol. 172, no. 6, December 1995 (1995-12-01), pages 1573 - 1580, XP001057722, ISSN: 0022-1899 *
VILCEK J ET AL: "Historical review: Cytokines as therapeutics and targets of therapeutics", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 4, April 2004 (2004-04-01), pages 201 - 209, XP004500540, ISSN: 0165-6147 *

Also Published As

Publication number Publication date
WO2006099451A2 (en) 2006-09-21
EP1859042A2 (en) 2007-11-28

Similar Documents

Publication Publication Date Title
WO2008060331A3 (en) Antibodies to sars coronavirus
NO20054078D0 (en) Human antibodies specific for Interleukin 15 (IL15).
WO2006085961A3 (en) Anti-mcp-1 antibodies, compositions, methods and uses
BRPI0513029A (en) method for producing a carbamylated erythropoietin protein, carbamylated erythropoietin protein, compound, pharmaceutical composition, methods of treating a chronic, sub-chronic and acute disease or condition and treating a disease of the central nervous system or peripheral nervous system, and , use of a compound
BRPI0413272A (en) antibodies to c-met
ATE490984T1 (en) METHOD FOR PRODUCTION AND EVALUATION OF CYTOTOXICITY OF KIR2DL NK RECEPTOR ANTIBODIES
EA200702532A1 (en) ANTIBODIES AGAINST MSR-1, COMPOSITIONS, METHODS AND APPLICATIONS
WO2004003147A3 (en) Cngh0004 polypeptides, antibodies, compositions, methods and uses
IS8432A (en) Antibodies that bind to leukocyte receptor-4
WO2007046834A3 (en) Glp-1 agonists, compositions, methods and uses
AU2003220525A1 (en) Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
BRPI0821110B8 (en) anti-nr10/il31ra neutralizing antibody, pharmaceutical composition comprising said antibody and use thereof
MY141215A (en) Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, method and uses
WO2005005604A3 (en) Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
WO2006099451A3 (en) Novel human, feline, chicken and other animal interferons and uses thereof
BRPI0514124B8 (en) monoclonal antibodies specific for human il-4, their use, pharmaceutical composition comprising them, and polynucleotides
DE602004016385D1 (en) COMPOSITIONS WITH PANTOTHENIC ACID OR DERIVATIVES AND THEIR USE TO STIMULATE APPETITE
WO2004067567A3 (en) Anti-dengue virus antibodies, compositions, methods and uses
WO2003038041A3 (en) Il-4 mutein proteins, antibodies, compositions, methods and uses
WO2009108252A3 (en) Method for stimulating immune response against moraxella catarrhalis
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
GB0324656D0 (en) A protein involved in ovarian cancer
WO2004094651A3 (en) Novel human polypeptides encoded by polynucleotides
WO2003057821A3 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2003102017A3 (en) Anti-relp fusion antibodies, compositions, methods and uses

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006748385

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application